pyro(l-alpha-aminoadipyl)-l-histidyl-l-thiazolidine-4-carboxamide has been researched along with naloxone in 3 studies
| Studies (pyro(l-alpha-aminoadipyl)-l-histidyl-l-thiazolidine-4-carboxamide) | Trials (pyro(l-alpha-aminoadipyl)-l-histidyl-l-thiazolidine-4-carboxamide) | Recent Studies (post-2010) (pyro(l-alpha-aminoadipyl)-l-histidyl-l-thiazolidine-4-carboxamide) | Studies (naloxone) | Trials (naloxone) | Recent Studies (post-2010) (naloxone) |
|---|---|---|---|---|---|
| 47 | 0 | 0 | 20,134 | 1,257 | 3,321 |
| Protein | Taxonomy | pyro(l-alpha-aminoadipyl)-l-histidyl-l-thiazolidine-4-carboxamide (IC50) | naloxone (IC50) |
|---|---|---|---|
| Cytochrome P450 2D6 | Homo sapiens (human) | 2 | |
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.043 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0219 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0019 | |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0019 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.0397 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.1896 | |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.05 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 0.0795 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.0154 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.0089 | |
| Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.0055 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhargava, HN; Matwyshyn, GA | 1 |
| Faden, AI | 1 |
| Ezra, D; Faden, AI; Feuerstein, G; Lux, WE; Snyder, F | 1 |
3 other study(ies) available for pyro(l-alpha-aminoadipyl)-l-histidyl-l-thiazolidine-4-carboxamide and naloxone
| Article | Year |
|---|---|
Comparative effects of thyrotropin releasing hormone, MK-771 and DN-1417 on morphine abstinence syndrome.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anticonvulsants; Body Temperature; Body Weight; Male; Mice; Morphine Dependence; Naloxone; Substance Withdrawal Syndrome; Thiazolidines; Thyrotropin-Releasing Hormone; Time Factors | 1985 |
New pharmacologic approaches to spinal cord injury: opiate antagonists and thyrotropin-releasing hormone.
Topics: Animals; Azocines; Cats; Endorphins; Enkephalin, Leucine; Humans; Naloxone; Narcotic Antagonists; Rabbits; Receptors, Opioid; Spinal Cord Injuries; Thiazolidines; Thyrotropin-Releasing Hormone | 1985 |
Hypotension produced by platelet-activating factor is reversed by thyrotropin-releasing hormone.
Topics: Animals; Blood Pressure; Guinea Pigs; Hypotension; Male; Naloxone; Platelet Activating Factor; Thiazolidines; Thyrotropin-Releasing Hormone; Time Factors | 1984 |